| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Societal CDMO, Inc. | Director | Common Stock | 164,046 | $57,416 | $0.3500 | 18 May 2022 | Direct |
| Societal CDMO, Inc. | Director | Stock Option (right to buy) | 118,182 | 18 May 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000106299322013175-berelowitz-michael-2022-05-18 | Societal CDMO, Inc. | 18 May 2022 | 2 | $0 | 4 | Director | 20 May 2022, 17:37 |
| /report/000119248221000433-berelowitz-michael-2021-04-20-restatement | Recro Pharma, Inc. | 20 Apr 2021 | 1 | $0 | 4/A | Director | 17 May 2021, 16:07 |